Microbix Biosystems Inc. (TSX:MBX)
Canada · Delayed Price · Currency is CAD 0.2550
0.00 (0.00%)
May 1, 2026, 3:57 PM EST
Microbix Biosystems Market Cap
Microbix Biosystems has a market cap or net worth of CAD 35.2 million as of May 1, 2026. Its market cap has decreased by -33.35% in one year.
Market Cap
35.20M
Enterprise Value
32.97M
Revenue
16.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.26
Market Cap Chart
Since October 1, 1992, Microbix Biosystems's market cap has increased from 13.38M to 35.20M, an increase of 163.02%. That is a compound annual growth rate of 2.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 35.20M | 10.10% |
| Dec 31, 2025 | 31.97M | -41.99% |
| Dec 31, 2024 | 55.10M | 3.47% |
| Dec 29, 2023 | 53.25M | -6.55% |
| Dec 30, 2022 | 56.99M | -47.62% |
| Dec 31, 2021 | 108.80M | 135.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NurExone Biologic | 50.63M |
| Medicenna Therapeutics | 49.22M |
| Quantum BioPharma | 45.47M |
| Defence Therapeutics | 43.09M |
| BriaCell Therapeutics | 41.33M |
| Telescope Innovations | 39.19M |
| MedMira | 38.60M |
| Lobe Sciences | 38.35M |